Keith Nuechterlein - Publications

Affiliations: 
University of California, Los Angeles, Los Angeles, CA 

295 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Kuo SS, Ventura J, Forsyth JK, Subotnik KL, Turner LR, Nuechterlein KH. Developmental trajectories of premorbid functioning predict cognitive remediation treatment response in first-episode schizophrenia. Psychological Medicine. 1-10. PMID 36349373 DOI: 10.1017/S0033291722003312  0.438
2022 Williamson DJ, Nuechterlein KH, Tishler T, Ventura J, Ellingson BM, Turkoz I, Keefe RSE, Alphs L. Dispersion of cognitive performance test scores on the MATRICS Consensus Cognitive Battery: A different perspective. Schizophrenia Research. Cognition. 30: 100270. PMID 36111288 DOI: 10.1016/j.scog.2022.100270  0.356
2022 Abplanalp SJ, Braff DL, Light GA, Nuechterlein KH, Green MF. Understanding Connections and Boundaries Between Positive Symptoms, Negative Symptoms, and Role Functioning Among Individuals With Schizophrenia: A Network Psychometric Approach. Jama Psychiatry. PMID 35976655 DOI: 10.1001/jamapsychiatry.2022.2386  0.513
2022 Alphs L, Baker P, Brown B, Fu DJ, Turkoz I, Nuechterlein KH. Evaluation of major treatment failure in patients with recent-onset schizophrenia or schizophreniform disorder: A post hoc analysis from the Disease Recovery Evaluation and Modification (DREaM) study. Schizophrenia Research. 248: 58-63. PMID 35939921 DOI: 10.1016/j.schres.2022.07.015  0.339
2022 Patterson TK, Nuechterlein KH, Subotnik KL, Castel AD, Knowlton BJ. Value-directed remembering in first-episode schizophrenia. Neuropsychology. PMID 35737534 DOI: 10.1037/neu0000840  0.448
2022 Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, Bryois J, Chen CY, Dennison CA, Hall LS, Lam M, Watanabe K, Frei O, Ge T, Harwood JC, ... ... Nuechterlein KH, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. PMID 35396580 DOI: 10.1038/s41586-022-04434-5  0.516
2022 Alphs L, Brown B, Turkoz I, Baker P, Fu DJ, Nuechterlein KH. The Disease Recovery Evaluation and Modification (DREaM) study: Effectiveness of paliperidone palmitate versus oral antipsychotics in patients with recent-onset schizophrenia or schizophreniform disorder. Schizophrenia Research. 243: 86-97. PMID 35247794 DOI: 10.1016/j.schres.2022.02.019  0.329
2021 Seabury RD, Bearden CE, Ventura J, Subotnik KL, Nuechterlein KH, Cannon TD. Confident memory errors and disrupted reality testing in early psychosis. Schizophrenia Research. 238: 170-177. PMID 34710715 DOI: 10.1016/j.schres.2021.10.007  0.575
2021 Fernandez VG, Asarnow R, Hodges M, Nuechterlein KH. Linguistic and neurocognitive correlates of probabilistic classification learning in schizophrenia. Schizophrenia Research. Cognition. 26: 100209. PMID 34354933 DOI: 10.1016/j.scog.2021.100209  0.406
2021 Joshi YB, Thomas ML, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, MacDonald LR, Molina JL, Nungaray JA, Radant AD, Silverman JM, et al. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia. The American Journal of Psychiatry. appiajp202020081212. PMID 33985348 DOI: 10.1176/appi.ajp.2020.20081212  0.603
2021 Wang C, Oughourlian T, Tishler TA, Anwar F, Raymond C, Pham AD, Perschon A, Villablanca JP, Ventura J, Subotnik KL, Nuechterlein KH, Ellingson BM. Cortical morphometric correlational networks associated with cognitive deficits in first episode schizophrenia. Schizophrenia Research. 231: 179-188. PMID 33872855 DOI: 10.1016/j.schres.2021.04.001  0.417
2021 Zito MF, Subotnik KL, Ventura J, Kern RS, Green MF, Nuechterlein KH. Awareness of illness is associated with better social and nonsocial cognition in recent-onset schizophrenia. Schizophrenia Research. 231: 51-53. PMID 33770625 DOI: 10.1016/j.schres.2021.02.020  0.62
2021 Tan EJ, Rossell SL, Subotnik KL, Ventura J, Nuechterlein KH. Cognitive heterogeneity in first-episode psychosis and its relationship with premorbid developmental adjustment. Psychological Medicine. 1-10. PMID 33706841 DOI: 10.1017/S0033291721000738  0.38
2021 Maj M, van Os J, De Hert M, Gaebel W, Galderisi S, Green MF, Guloksuz S, Harvey PD, Jones PB, Malaspina D, McGorry P, Miettunen J, Murray RM, Nuechterlein KH, Peralta V, et al. The clinical characterization of the patient with primary psychosis aimed at personalization of management. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 20: 4-33. PMID 33432763 DOI: 10.1002/wps.20809  0.435
2020 Reavis EA, Lee J, Altshuler LL, Cohen MS, Engel SA, Glahn DC, Jimenez AM, Narr KL, Nuechterlein KH, Riedel P, Wynn JK, Green MF. Structural and Functional Connectivity of Visual Cortex in Schizophrenia and Bipolar Disorder: A Graph-Theoretic Analysis. Schizophrenia Bulletin Open. 1: sgaa056. PMID 33313506 DOI: 10.1093/schizbullopen/sgaa056  0.46
2020 McCleery A, Wynn JK, Lee J, Reavis EA, Ventura J, Subotnik KL, Green MF, Nuechterlein KH. Early Visual Processing Is Associated With Social Cognitive Performance in Recent-Onset Schizophrenia. Frontiers in Psychiatry. 11: 823. PMID 33192628 DOI: 10.3389/Fpsyt.2020.00823  0.805
2020 Greenwood TA, Swerdlow NR, Sprock J, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Silverman JM, Stone WS, Sugar CA, et al. Heritability of acoustic startle magnitude and latency from the consortium on the genetics of schizophrenia. Schizophrenia Research. PMID 33189519 DOI: 10.1016/j.schres.2020.11.003  0.579
2020 Nuechterlein KH, Ventura J, Subotnik KL, Gretchen-Doorly D, Turner LR, Casaus LR, Luo J, Boucher ML, Hayata JN, Bell MD, Medalia A. A randomized controlled trial of cognitive remediation and long-acting injectable risperidone after a first episode of schizophrenia: improving cognition and work/school functioning. Psychological Medicine. 1-10. PMID 32981534 DOI: 10.1017/S0033291720003335  0.472
2020 Lee J, Green MF, Nuechterlein KH, Swerdlow NR, Greenwood TA, Hellemann GS, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, et al. The effects of age and sex on cognitive impairment in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS) study. Plos One. 15: e0232855. PMID 32401791 DOI: 10.1371/Journal.Pone.0232855  0.593
2020 Subotnik KL, Ventura J, Hellemann GS, Zito MF, Agee ER, Nuechterlein KH. Relationship of poor insight to neurocognition, social cognition, and psychiatric symptoms in schizophrenia: A meta-analysis. Schizophrenia Research. PMID 32334936 DOI: 10.1016/J.Schres.2020.03.038  0.46
2020 Bezdicek O, Michalec J, Kališová L, Kufa T, Děchtěrenko F, Chlebovcová M, Havlík F, Green MF, Nuechterlein KH. Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery. Schizophrenia Research. PMID 32089475 DOI: 10.1016/J.Schres.2020.02.004  0.606
2020 Ventura J, McEwen S, Subotnik KL, Hellemann GS, Ghadiali M, Rahimdel A, Seo MJ, Irwin MR, Nuechterlein KH. Changes in inflammation are related to depression and amount of aerobic exercise in first episode schizophrenia. Early Intervention in Psychiatry. PMID 32056388 DOI: 10.1111/Eip.12946  0.463
2020 Reed AC, Lee J, Green MF, Hamilton HK, Miller GA, Subotnik KL, Ventura J, Nuechterlein KH, Yee CM. Associations between physiological responses to social-evaluative stress and daily functioning in first-episode schizophrenia. Schizophrenia Research. PMID 31948901 DOI: 10.1016/J.Schres.2019.12.040  0.779
2020 Nuechterlein K, Ventura J, McEwen S, Subotnik K, Turner L, Boucher M, Distler M, Casaus L. O4.1. AEROBIC EXERCISE DOSE DETERMINES THE COGNITIVE GAIN IN FIRST-EPISODE SCHIZOPHRENIA, SO HOW DO WE ENCOURAGE SUFFICIENT EXERCISE? Schizophrenia Bulletin. 46: S8-S9. DOI: 10.1093/Schbul/Sbaa028.018  0.334
2020 Joshi Y, Michael T, Molina J, MacDonald L, Nungaray J, Cardoso L, Sprock J, Braff D, Green M, Nuechterlein K, Stone W, Gur R, Gur R, Swerdlow N, Light G. Impact of Anticholinergic Medication Burden on Cognition in Schizophrenia in the Consortium on the Genetics of Schizophrenia (COGS-2) Study Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.1029  0.67
2019 McCleery A, Nuechterlein KH. Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations
. Dialogues in Clinical Neuroscience. 21: 239-248. PMID 31749648 DOI: 10.31887/Dcns.2019.21.3/Amccleery  0.716
2019 Greenwood TA, Lazzeroni LC, Maihofer AX, Swerdlow NR, Calkins ME, Freedman R, Green MF, Light GA, Nievergelt CM, Nuechterlein KH, Radant AD, Siever LJ, Silverman JM, Stone WS, Sugar CA, et al. Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study. Jama Psychiatry. PMID 31596458 DOI: 10.1001/Jamapsychiatry.2019.2850  0.603
2019 Bonfils KA, Ventura J, Subotnik KL, Nuechterlein KH. Affective prosody and facial emotion recognition in first-episode schizophrenia: Associations with functioning & symptoms. Schizophrenia Research. Cognition. 18: 100153. PMID 31497511 DOI: 10.1016/j.scog.2019.100153  0.383
2019 Bigdeli TB, Nuechterlein KH, Sugar CA, Subotnik KL, Kubarych T, Neale MC, Kendler KS, Asarnow RF. Evidence of shared familial factors influencing neurocognitive endophenotypes in adult- and childhood-onset schizophrenia. Psychological Medicine. 1-8. PMID 31362798 DOI: 10.1017/S0033291719001715  0.437
2019 Ventura J, Welikson T, Ered A, Subotnik KL, Keefe RSE, Hellemann GS, Nuechterlein KH. Virtual reality assessment of functional capacity in the early course of schizophrenia: Associations with cognitive performance and daily functioning. Early Intervention in Psychiatry. PMID 31183960 DOI: 10.1111/Eip.12831  0.824
2019 Mahncke HW, Kim SJ, Rose A, Stasio C, Buckley P, Caroff S, Duncan E, Yasmin S, Jarskog LF, Lamberti JS, Nuechterlein K, Strassnig M, Velligan D, Ventura J, Walker T, et al. Evaluation of a plasticity-based cognitive training program in schizophrenia: Results from the eCaesar trial. Schizophrenia Research. PMID 30930034 DOI: 10.1016/J.Schres.2019.03.006  0.466
2019 Nuechterlein KH, Subotnik KL, Ventura J, Turner LR, Gitlin MJ, Gretchen-Doorly D, Becker DR, Drake RE, Wallace CJ, Liberman RP. Enhancing return to work or school after a first episode of schizophrenia: the UCLA RCT of Individual Placement and Support and Workplace Fundamentals Module training. Psychological Medicine. 1-9. PMID 30606273 DOI: 10.1017/S0033291718003860  0.355
2019 Nuechterlein K, Subotnik K, Ventura J, Turner L, Becker D, Drake R. O9.7. The Complementary Roles Of Cognition And Supported Education/Employment In The Early Course Of Schizophrenia Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz021.247  0.491
2019 Ventura J, McEwan S, Subotnik K, Hellemann G, Ghadiali M, Rahimdal A, Sou MJ, Irwin M, Nuechterlein K. F12. Changes In Brain Inflammation Are Related To Symptoms And Aerobic Exercise In First Episode Schizophrenia Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz018.424  0.428
2019 Diehl C, Bartholomew ME, Karlsgodt KH, Cannon TD, Lake JI, Reed AC, Miller GA, Green MF, Subotnik K, Ventura J, Nuechterlein K, Yee CM. F184. White Matter Structural Integrity and Working Memory Resilience to Stress in Schizophrenia Biological Psychiatry. 85: S284-S285. DOI: 10.1016/J.Biopsych.2019.03.721  0.817
2018 Lee J, Reavis EA, Engel SA, Altshuler LL, Cohen MS, Glahn DC, Nuechterlein KH, Wynn JK, Green MF. fMRI evidence of aberrant neural adaptation for objects in schizophrenia and bipolar disorder. Human Brain Mapping. PMID 30575206 DOI: 10.1002/Hbm.24472  0.409
2018 Breier A, Buchanan RW, D'Souza D, Nuechterlein K, Marder S, Dunn W, Preskorn S, Macaluso M, Wurfel B, Maguire G, Kakar R, Highum D, Hoffmeyer D, Coskinas E, Litman R, et al. Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study. Schizophrenia Research. PMID 30478008 DOI: 10.1016/J.Schres.2018.11.002  0.552
2018 Clayson PE, Kern RS, Nuechterlein KH, Knowlton BJ, Bearden CE, Cannon TD, Fiske AP, Ghermezi L, Hayata JN, Hellemann GS, Horan WP, Kee K, Lee J, Subotnik KL, Sugar CA, et al. Social vs. non-social measures of learning potential for predicting community functioning across phase of illness in schizophrenia. Schizophrenia Research. PMID 30121183 DOI: 10.1016/J.Schres.2018.07.046  0.778
2018 Laloyaux J, Van der Linden M, Nuechterlein KH, Thonon B, Larøi F. A direct examination of the cognitive underpinnings of multitasking abilities: A first study examining schizophrenia. Psychiatry Research. 268: 288-296. PMID 30081201 DOI: 10.1016/j.psychres.2018.06.060  0.483
2018 Grazioplene RG, Bearden CE, Subotnik KL, Ventura J, Haut K, Nuechterlein KH, Cannon TD. Connectivity-enhanced diffusion analysis reveals white matter density disruptions in first episode and chronic schizophrenia. Neuroimage. Clinical. 18: 608-616. PMID 29845009 DOI: 10.1016/J.Nicl.2018.02.015  0.504
2018 Tishler TA, Bartzokis G, Lu PH, Raven EP, Khanoyan M, Kirkpatrick CJ, Pyle MH, Villablanca JP, Altshuler LL, Mintz J, Ventura J, Casaus LR, Subotnik KL, Nuechterlein KH, Ellingson BM. Abnormal Trajectory of Intracortical Myelination in Schizophrenia Implicates White Matter in Disease Pathophysiology and the Therapeutic Mechanism of Action of Antipsychotics. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 3: 454-462. PMID 29735155 DOI: 10.1016/J.Bpsc.2017.03.007  0.366
2018 Fernandez VG, Asarnow R, Narr KL, Subotnik KL, Kuppinger H, Fogelson D, Nuechterlein KH. Temporal lobe thickness and verbal memory in first-degree relatives of individuals with schizophrenia. Schizophrenia Research. PMID 29499968 DOI: 10.1016/J.Schres.2018.02.038  0.4
2018 Nuechterlein K, McEwen S, Ventura J, Subotnik K, Turner L, Boucher M, Casaus L, Hayata J. 11.4 Aerobic Exercise Enhances Cognitive Training Effects In First Episode Schizophrenia: Cognitive And Functional Gains And Promising Biological Mechanisms Of Action. Schizophrenia Bulletin. 44. DOI: 10.1093/Schbul/Sby014.042  0.475
2018 Nuechterlein K. 11. Aerobic Exercise Training For Individuals With Schizophrenia: The Broad Benefits Across Physical Health, Cognition, And Everyday Functioning And Promising Mechanisms Of Action Schizophrenia Bulletin. 44. DOI: 10.1093/Schbul/Sby014.038  0.446
2018 Greenwood T, Lazzeroni L, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light G, Nuechterlein K, Olincy A, Radant A, Seidman L, Siever L, Silverman J, Stone W, et al. S209. Genome-Wide Association of Endophenotypes for Schizophrenia From the Consortium On the Genetics of Schizophrenia (COGS) Study Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.1101  0.634
2017 Hamilton HK, Williams TJ, Ventura J, Jasperse LJ, Owens EM, Miller GA, Subotnik KL, Nuechterlein KH, Yee CM. Clinical and Cognitive Significance of Auditory Sensory Processing Deficits in Schizophrenia. The American Journal of Psychiatry. appiajp201716111203. PMID 29202656 DOI: 10.1176/Appi.Ajp.2017.16111203  0.845
2017 Ventura J, Subotnik KL, Gretchen-Doorly D, Casaus L, Boucher M, Hellemann GS, Nuechterlein KH. Cognitive remediation can improve negative symptoms and social functioning in first-episode schizophrenia: A randomized controlled trial. Schizophrenia Research. PMID 29128326 DOI: 10.1016/J.Schres.2017.10.005  0.52
2017 Lee J, Nuechterlein KH, Knowlton BJ, Bearden CE, Cannon TD, Fiske AP, Ghermezi L, Hayata JN, Hellemann GS, Horan WP, Kee K, Kern RS, Subotnik KL, Sugar CA, Ventura J, et al. Episodic Memory for Dynamic Social Interaction Across Phase of Illness in Schizophrenia. Schizophrenia Bulletin. PMID 29106694 DOI: 10.1093/Schbul/Sbx081  0.648
2017 Mucci A, Galderisi S, Green MF, Nuechterlein K, Rucci P, Gibertoni D, Rossi A, Rocca P, Bertolino A, Bucci P, Hellemann G, Spisto M, Palumbo D, Aguglia E, Amodeo G, et al. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives. Psychological Medicine. 1-10. PMID 29017620 DOI: 10.1017/S0033291717002902  0.625
2017 Nuechterlein KH. The Pioneering Contributions of Irving Gottesman: An Appreciation. Clinical Psychological Science : a Journal of the Association For Psychological Science. 5: 424-426. PMID 28948093 DOI: 10.1177/2167702617691484  0.415
2017 Reavis EA, Lee J, Wynn JK, Engel SA, Cohen MS, Nuechterlein KH, Glahn DC, Altshuler LL, Green MF. Assessing neural tuning for object perception in schizophrenia and bipolar disorder with multivariate pattern analysis of fMRI data. Neuroimage. Clinical. 16: 491-497. PMID 28932681 DOI: 10.1016/J.Nicl.2017.08.023  0.554
2017 Swerdlow NR, Light GA, Thomas ML, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension. Schizophrenia Research. PMID 28549722 DOI: 10.1016/J.Schres.2017.05.013  0.557
2017 Blanchard JJ, Bradshaw KR, Garcia CP, Nasrallah HA, Harvey PD, Casey D, Csoboth CT, Hudson JI, Julian L, Lentz E, Nuechterlein KH, Perkins DO, Skale TG, Snowden LR, Tandon R, et al. Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study. Schizophrenia Research. PMID 28087270 DOI: 10.1016/J.Schres.2017.01.011  0.394
2017 Tishler T, Bartzokis G, Alphs L, Brown B, Yue Y, Villablanca P, Subotnik K, Nuechterlein K, Ellingson B. SU78. Intracortical Myelination Within the Frontal Lobe as a Potential Biomarker for Therapeutic Effectiveness in Antipsychotics Using MRI With Selective Myelin-Lipid Suppression at 1.5 and 3 T Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx024.075  0.372
2017 Subotnik K, Asarnow R, Fogelson D, Kendler K, Heidi K, Woo S, Bayles B, Nuechterlein K. SA96. Schizophrenia and Schizophrenia-Spectrum Disorders in the First-Degree Relatives of Children and Adults With Schizophrenia: The UCLA Family Study Schizophrenia Bulletin. 43: S147-S147. DOI: 10.1093/Schbul/Sbx023.094  0.556
2017 Grazioplene R, Bearden C, Subotnik K, Ventura J, Green MF, Nuechterlein K, Cannon T. 85. Diffusion Imaging of White Matter Pathways in Schizophrenia: Are Illness-Linked Changes Progressive? Schizophrenia Bulletin. 43: S47-S47. DOI: 10.1093/Schbul/Sbx021.124  0.654
2017 Reavis E, Lee J, Wynn J, Engel S, Cohen M, Nuechterlein K, Glahn D, Hoy J, Polon N, Green M. 82. Assessing Fidelity of Object Representations in Visual Cortex in Schizophrenia and Bipolar Disorder Using Multivariate Pattern Analysis Schizophrenia Bulletin. 43: S46-S46. DOI: 10.1093/Schbul/Sbx021.121  0.57
2017 Reed A, Lake J, Hamilton H, Bachman P, Clayson P, Miller G, Subotnik K, Nuechterlein K, Yee C. 70. Cortisol Response to Psychosocial Stress and Working Memory Performance in Schizophrenia Schizophrenia Bulletin. 43: S41-S41. DOI: 10.1093/Schbul/Sbx021.109  0.806
2017 McEwen S, Jarrahi B, Subotnik K, Ventura J, Nuechterlein K. 396. Neuroplasticity Benefits of Adding Aerobic Exercise to Cognitive Training in First-Episode Schizophrenia Patients Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.413  0.469
2016 Thomas ML, Green MF, Hellemann G, Sugar CA, Tarasenko M, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Shiluk AL, Siever LJ, et al. Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia. Jama Psychiatry. PMID 27926742 DOI: 10.1001/Jamapsychiatry.2016.2980  0.586
2016 Firth J, Stubbs B, Rosenbaum S, Vancampfort D, Malchow B, Schuch F, Elliott R, Nuechterlein KH, Yung AR. Aerobic Exercise Improves Cognitive Functioning in People With Schizophrenia: A Systematic Review and Meta-Analysis. Schizophrenia Bulletin. PMID 27521348 DOI: 10.1093/Schbul/Sbw115  0.356
2016 McCleery A, Lee J, Fiske AP, Ghermezi L, Hayata JN, Hellemann GS, Horan WP, Kee KS, Kern RS, Knowlton BJ, Subotnik KL, Ventura J, Sugar CA, Nuechterlein KH, Green MF. Longitudinal stability of social cognition in schizophrenia: A 5-year follow-up of social perception and emotion processing. Schizophrenia Research. PMID 27443808 DOI: 10.1016/J.Schres.2016.07.008  0.784
2016 Millard SP, Shofer J, Braff D, Calkins M, Cadenhead K, Freedman R, Green MF, Greenwood TA, Gur R, Gur R, Lazzeroni LC, Light GA, Olincy A, Nuechterlein K, Seidman L, et al. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study. Schizophrenia Research. PMID 27132484 DOI: 10.1016/J.Schres.2016.04.011  0.606
2016 Jimenez AM, Lee J, Wynn JK, Cohen MS, Engel SA, Glahn DC, Nuechterlein KH, Reavis EA, Green MF. Abnormal Ventral and Dorsal Attention Network Activity during Single and Dual Target Detection in Schizophrenia. Frontiers in Psychology. 7: 323. PMID 27014135 DOI: 10.3389/Fpsyg.2016.00323  0.433
2016 Stone WS, Mesholam-Gately RI, Giuliano AJ, Woodberry KA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, ... ... Nuechterlein K, et al. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers. Schizophrenia Research. PMID 26896388 DOI: 10.1016/J.Schres.2016.02.003  0.658
2016 Ventura J, Subotnik KL, Ered A, Hellemann GS, Nuechterlein KH. Cognitive Assessment Interview (CAI): Validity as a co-primary measure of cognition across phases of schizophrenia. Schizophrenia Research. PMID 26852403 DOI: 10.1016/J.Schres.2016.01.028  0.753
2016 Rosenfarb IF, Triana S, Nuechterlein KH, Ventura J, Breitborde NJ. Expressed emotion and the escalation of depressive symptoms in individuals with recent-onset schizophrenia. Early Intervention in Psychiatry. PMID 26801739 DOI: 10.1111/Eip.12307  0.341
2015 Sumiyoshi C, Harvey PD, Takaki M, Okahisa Y, Sato T, Sora I, Nuechterlein KH, Subotnik KL, Sumiyoshi T. Factors predicting work outcome in Japanese patients with schizophrenia: role of multiple functioning levels. Schizophrenia Research. Cognition. 2: 105-112. PMID 29379760 DOI: 10.1016/J.Scog.2015.07.003  0.39
2015 Greenwood TA, Lazzeroni LC, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, et al. Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. Schizophrenia Research. PMID 26597662 DOI: 10.1016/J.Schres.2015.11.008  0.522
2015 McEwen SC, Hardy A, Ellingson BM, Jarrahi B, Sandhu N, Subotnik KL, Ventura J, Nuechterlein KH. Prefrontal and Hippocampal Brain Volume Deficits: Role of Low Physical Activity on Brain Plasticity in First-Episode Schizophrenia Patients. Journal of the International Neuropsychological Society : Jins. 21: 868-79. PMID 26581798 DOI: 10.1017/S1355617715000983  0.39
2015 McCleery A, Green MF, Hellemann GS, Baade LE, Gold JM, Keefe RS, Kern RS, Mesholam-Gately RI, Seidman LJ, Subotnik KL, Ventura J, Nuechterlein KH. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). Psychological Medicine. 1. PMID 26537981 DOI: 10.1017/S0033291715002433  0.793
2015 Greenwood TA, Light GA, Swerdlow NR, Calkins ME, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, et al. Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History. The American Journal of Psychiatry. appiajp201515050605. PMID 26441157 DOI: 10.1176/Appi.Ajp.2015.15050605  0.493
2015 Rodriguez-Jimenez R, Dompablo M, Bagney A, Santabárbara J, Aparicio AI, Torio I, Moreno-Ortega M, Lopez-Anton R, Lobo A, Kern RS, Green MF, Jimenez-Arriero MA, Santos JL, Nuechterlein KH, Palomo T. The MCCB impairment profile in a Spanish sample of patients with schizophrenia: Effects of diagnosis, age, and gender on cognitive functioning. Schizophrenia Research. PMID 26416441 DOI: 10.1016/J.Schres.2015.09.013  0.559
2015 Subotnik KL, Casaus LR, Ventura J, Luo JS, Hellemann GS, Gretchen-Doorly D, Marder S, Nuechterlein KH. Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia : A Randomized Clinical Trial. Jama Psychiatry. PMID 26107752 DOI: 10.1001/Jamapsychiatry.2015.0270  0.421
2015 Nasrallah HA, Harvey PD, Casey D, Csoboth CT, Hudson JI, Julian L, Lentz E, Nuechterlein KH, Perkins DO, Kotowsky N, Skale TG, Snowden LR, Tandon R, Tek C, Velligan D, et al. The Management of Schizophrenia in Clinical Practice (MOSAIC) Registry: A focus on patients, caregivers, illness severity, functional status, disease burden and healthcare utilization. Schizophrenia Research. PMID 26027848 DOI: 10.1016/J.Schres.2015.04.031  0.472
2015 McCleery A, Green MF, Hellemann GS, Baade LE, Gold JM, Keefe RS, Kern RS, Mesholam-Gately RI, Seidman LJ, Subotnik KL, Ventura J, Nuechterlein KH. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). Psychological Medicine. 1-10. PMID 25916421 DOI: 10.1017/S0033291715000641  0.807
2015 Marino L, Nossel I, Choi JC, Nuechterlein K, Wang Y, Essock S, Bennett M, McNamara K, Mendon S, Dixon L. The RAISE Connection Program for Early Psychosis: Secondary Outcomes and Mediators and Moderators of Improvement. The Journal of Nervous and Mental Disease. 203: 365-71. PMID 25900546 DOI: 10.1097/Nmd.0000000000000293  0.316
2015 Haut KM, van Erp TG, Knowlton B, Bearden CE, Subotnik K, Ventura J, Nuechterlein KH, Cannon TD. Contributions of Feature Binding During Encoding and Functional Connectivity of the Medial Temporal Lobe Structures to Episodic Memory Deficits Across the Prodromal and First-Episode Phases of Schizophrenia. Clinical Psychological Science : a Journal of the Association For Psychological Science. 3: 159-174. PMID 25750836 DOI: 10.1177/2167702614533949  0.59
2015 Nuechterlein KH, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, et al. Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 163: 38-46. PMID 25749017 DOI: 10.1016/J.Schres.2015.01.017  0.621
2015 Seidman LJ, Hellemann G, Nuechterlein KH, Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Freedman R, Gur RE, Gur RC, Lazzeroni LC, Light GA, Olincy A, Radant AD, Siever LJ, et al. Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1). Schizophrenia Research. 163: 73-9. PMID 25682549 DOI: 10.1016/J.Schres.2015.01.027  0.583
2015 Ventura J, Ered A, Gretchen-Doorly D, Subotnik KL, Horan WP, Hellemann GS, Nuechterlein KH. Theory of mind in the early course of schizophrenia: stability, symptom and neurocognitive correlates, and relationship with functioning. Psychological Medicine. 1-13. PMID 25647289 DOI: 10.1017/S0033291714003171  0.796
2015 Radant AD, Millard SP, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Meichle SP, Nuechterlein KH, Olincy A, et al. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies. Schizophrenia Research. 163: 47-52. PMID 25553977 DOI: 10.1016/J.Schres.2014.12.016  0.63
2015 Ventura J, Subotnik KL, Gitlin MJ, Gretchen-Doorly D, Ered A, Villa KF, Hellemann GS, Nuechterlein KH. Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8 years later. Schizophrenia Research. 161: 407-13. PMID 25499044 DOI: 10.1016/J.Schres.2014.10.043  0.789
2015 Stone WS, Mesholam-Gately RI, Braff DL, Calkins ME, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Siever LJ, et al. California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 163: 32-7. PMID 25497440 DOI: 10.1016/J.Schres.2014.10.029  0.509
2015 Pirnia T, Woods RP, Hamilton LS, Lyden H, Joshi SH, Asarnow RF, Nuechterlein KH, Narr KL. Hippocampal dysfunction during declarative memory encoding in schizophrenia and effects of genetic liability. Schizophrenia Research. 161: 357-66. PMID 25497222 DOI: 10.1016/J.Schres.2014.11.030  0.424
2015 Light GA, Swerdlow NR, Thomas ML, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Pela M, Radant AD, Seidman LJ, Sharp RF, Siever LJ, et al. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. Schizophrenia Research. 163: 63-72. PMID 25449710 DOI: 10.1016/J.Schres.2014.09.042  0.532
2015 Gur RC, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Neurocognitive performance in family-based and case-control studies of schizophrenia. Schizophrenia Research. 163: 17-23. PMID 25432636 DOI: 10.1016/J.Schres.2014.10.049  0.542
2015 Turetsky BI, Dress EM, Braff DL, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, et al. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2. Schizophrenia Research. 163: 53-62. PMID 25306203 DOI: 10.1016/J.Schres.2014.09.024  0.535
2015 Lee J, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, et al. Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications. Schizophrenia Research. 163: 24-31. PMID 25248939 DOI: 10.1016/J.Schres.2014.08.014  0.592
2014 Green MF, Harris JG, Nuechterlein KH. The MATRICS consensus cognitive battery: what we know 6 years later. The American Journal of Psychiatry. 171: 1151-4. PMID 25756630 DOI: 10.1176/Appi.Ajp.2014.14070936  0.607
2014 Nuechterlein KH, Ventura J, Subotnik KL, Hayata JN, Medalia A, Bell MD. Developing a Cognitive Training Strategy for First-Episode Schizophrenia: Integrating Bottom-Up and Top-Down Approaches. American Journal of Psychiatric Rehabilitation. 17: 225-253. PMID 25489275 DOI: 10.1080/15487768.2014.935674  0.412
2014 Hamilton HK, Sun JC, Green MF, Kee KS, Lee J, Sergi M, Sholty GL, Mathis KI, Jetton C, Williams TJ, Kern R, Horan W, Fiske A, Subotnik KL, Ventura J, ... ... Nuechterlein KH, et al. Social cognition and functional outcome in schizophrenia: The moderating role of cardiac vagal tone. Journal of Abnormal Psychology. 123: 764-70. PMID 25314266 DOI: 10.1037/A0037813  0.766
2014 Nahum M, Fisher M, Loewy R, Poelke G, Ventura J, Nuechterlein KH, Hooker CI, Green MF, Merzenich M, Vinogradov S. A novel, online social cognitive training program for young adults with schizophrenia: A pilot study. Schizophrenia Research. Cognition. 1: e11-e19. PMID 25267937 DOI: 10.1016/J.Scog.2014.01.003  0.581
2014 Gray BE, McMahon RP, Green MF, Seidman LJ, Mesholam-Gately RI, Kern RS, Nuechterlein KH, Keefe RS, Gold JM. Detecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery. Schizophrenia Research. 159: 182-7. PMID 25156338 DOI: 10.1016/J.Schres.2014.07.032  0.396
2014 Subotnik KL, Ventura J, Gretchen-Doorly D, Hellemann GS, Agee ER, Casaus LR, Luo JS, Villa KF, Nuechterlein KH. The impact of second-generation antipsychotic adherence on positive and negative symptoms in recent-onset schizophrenia. Schizophrenia Research. 159: 95-100. PMID 25108771 DOI: 10.1016/J.Schres.2014.07.008  0.431
2014 Nuechterlein KH, Ventura J, Subotnik KL, Bartzokis G. The early longitudinal course of cognitive deficits in schizophrenia. The Journal of Clinical Psychiatry. 75: 25-9. PMID 24919168 DOI: 10.4088/Jcp.13065.Su1.06  0.536
2014 Schmeidler J, Lazzeroni LC, Swerdlow NR, Ferreira RP, Braff DL, Calkins ME, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Olincy A, Nuechterlein KH, et al. Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblings. Psychiatry Research. 219: 67-71. PMID 24913833 DOI: 10.1016/J.Psychres.2014.05.035  0.53
2014 Light G, Greenwood TA, Swerdlow NR, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study. Schizophrenia Bulletin. 40: 1404-11. PMID 24903414 DOI: 10.1093/Schbul/Sbu064  0.531
2014 McCleery A, Ventura J, Kern RS, Subotnik KL, Gretchen-Doorly D, Green MF, Hellemann GS, Nuechterlein KH. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment. Schizophrenia Research. 157: 33-9. PMID 24888526 DOI: 10.1016/J.Schres.2014.04.039  0.793
2014 Lee J, Cohen MS, Engel SA, Glahn D, Nuechterlein KH, Wynn JK, Green MF. Neural substrates of visual masking by object substitution in schizophrenia. Human Brain Mapping. 35: 4654-62. PMID 24677632 DOI: 10.1002/Hbm.22501  0.579
2014 Ventura J, Subotnik KL, Ered A, Gretchen-Doorly D, Hellemann GS, Vaskinn A, Nuechterlein KH. The relationship of attitudinal beliefs to negative symptoms, neurocognition, and daily functioning in recent-onset schizophrenia. Schizophrenia Bulletin. 40: 1308-18. PMID 24561318 DOI: 10.1093/Schbul/Sbu002  0.82
2014 Tsuang D, Esterberg M, Braff D, Calkins M, Cadenhead K, Dobie D, Freedman R, Green MF, Greenwood T, Gur R, Gur R, Horan W, Lazzeroni LC, Light GA, Millard SP, ... ... Nuechterlein K, et al. Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia? Plos One. 9: e88379. PMID 24523888 DOI: 10.1371/Journal.Pone.0088379  0.637
2014 Swerdlow NR, Light GA, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Ray A, Seidman LJ, Siever LJ, Silverman JM, et al. Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS. Schizophrenia Research. 152: 503-12. PMID 24405980 DOI: 10.1016/J.Schres.2013.12.004  0.616
2014 Ered A, Ventura J, Subotnik K, Gretchen-Doorly D, Nuechterlein K. The cognitive assessment interview (CAI): performance and clinical, neurocognitive, & functional outcome correlates in schizophrenia patients F1000research. 5. DOI: 10.7490/F1000Research.1096928.1  0.818
2014 DeTore N, Ventura J, Gretchen-Doorly D, Subotnik K, Hellemann G, Nuechterlein K. The association between negative symptoms and family attitudes in first episode schizophrenia F1000research. 5. DOI: 10.7490/F1000Research.1096925.1  0.506
2014 Purcell J, Haut K, Subotnik K, Ventura J, Bearden C, Nuechterlein K, Cannon T. Reduced cerebellar activation and impaired associative memory in first episode schizophrenia F1000research. 5. DOI: 10.7490/F1000Research.1096921.1  0.645
2014 Sumiyoshi C, Harvey PD, Takaki M, Okahisa Y, Sato T, Sora I, Nuechterlein KH, Subotnik KL, Sumiyoshi T. Factors predicting work outcome in Japanese patients with schizophrenia: Role of multiple functioning levels Schizophrenia Research: Cognition. DOI: 10.1016/j.scog.2015.07.003  0.393
2013 Greenwood TA, Swerdlow NR, Gur RE, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Ray A, Schork NJ, et al. Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. The American Journal of Psychiatry. 170: 521-32. PMID 23511790 DOI: 10.1176/Appi.Ajp.2012.12020186  0.51
2013 Calkins ME, Ray A, Gur RC, Freedman R, Green MF, Greenwood TA, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar C, et al. Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biological Psychiatry. 73: 976-84. PMID 23395246 DOI: 10.1016/J.Biopsych.2012.12.021  0.578
2013 Joshi SH, Narr KL, Philips OR, Nuechterlein KH, Asarnow RF, Toga AW, Woods RP. Statistical shape analysis of the corpus callosum in Schizophrenia. Neuroimage. 64: 547-59. PMID 23000788 DOI: 10.1016/J.Neuroimage.2012.09.024  0.326
2012 Moran ZD, Williams TJ, Bachman P, Nuechterlein KH, Subotnik KL, Yee CM. Spectral decomposition of P50 suppression in schizophrenia during concurrent visual processing. Schizophrenia Research. 140: 237-42. PMID 22840844 DOI: 10.1016/J.Schres.2012.07.002  0.84
2012 Subotnik KL, Schell AM, Chilingar MS, Dawson ME, Ventura J, Kelly KA, Hellemann GS, Nuechterlein KH. The interaction of electrodermal activity and expressed emotion in predicting symptoms in recent-onset schizophrenia. Psychophysiology. 49: 1035-8. PMID 22680838 DOI: 10.1111/J.1469-8986.2012.01383.X  0.328
2012 Nuechterlein KH, Subotnik KL, Ventura J, Green MF, Gretchen-Doorly D, Asarnow RF. The puzzle of schizophrenia: tracking the core role of cognitive deficits. Development and Psychopathology. 24: 529-36. PMID 22559128 DOI: 10.1017/S0954579412000132  0.635
2012 Yang Y, Nuechterlein KH, Phillips OR, Gutman B, Kurth F, Dinov I, Thompson PM, Asarnow RF, Toga AW, Narr KL. Disease and genetic contributions toward local tissue volume disturbances in schizophrenia: a tensor-based morphometry study. Human Brain Mapping. 33: 2081-91. PMID 22241649 DOI: 10.1002/Hbm.21349  0.458
2012 Rodriguez-Jimenez R, Bagney A, Garcia-Navarro C, Aparicio AI, Lopez-Anton R, Moreno-Ortega M, Jimenez-Arriero MA, Santos JL, Lobo A, Kern RS, Green MF, Nuechterlein KH, Palomo T. The MATRICS consensus cognitive battery (MCCB): co-norming and standardization in Spain. Schizophrenia Research. 134: 279-84. PMID 22192501 DOI: 10.1016/j.schres.2011.11.026  0.475
2012 Gretchen-Doorly D, Kite RE, Subotnik KL, Detore NR, Ventura J, Kurtz AS, Nuechterlein KH. Cardiorespiratory endurance, muscular flexibility and strength in first-episode schizophrenia patients: use of a standardized fitness assessment. Early Intervention in Psychiatry. 6: 185-90. PMID 22168582 DOI: 10.1111/j.1751-7893.2011.00313.x  0.437
2012 Horan WP, Green MF, DeGroot M, Fiske A, Hellemann G, Kee K, Kern RS, Lee J, Sergi MJ, Subotnik KL, Sugar CA, Ventura J, Nuechterlein KH. Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophrenia Bulletin. 38: 865-72. PMID 21382881 DOI: 10.1093/Schbul/Sbr001  0.568
2012 Green MF, Bearden CE, Cannon TD, Fiske AP, Hellemann GS, Horan WP, Kee K, Kern RS, Lee J, Sergi MJ, Subotnik KL, Sugar CA, Ventura J, Yee CM, Nuechterlein KH. Social cognition in schizophrenia, Part 1: performance across phase of illness. Schizophrenia Bulletin. 38: 854-64. PMID 21345917 DOI: 10.1093/Schbul/Sbq171  0.663
2012 Velligan DI, Rubin M, Fredrick MM, Mintz J, Nuechterlein KH, Schooler NR, Jaeger J, Peters NM, Buller R, Marder SR, Dube S. The cultural adaptability of intermediate measures of functional outcome in schizophrenia. Schizophrenia Bulletin. 38: 630-41. PMID 21134973 DOI: 10.1093/schbul/sbq136  0.348
2012 Nuechterlein K. Maximizing Successful Return To School Or Work After An Initial Episode Of Schizophrenia Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70049-X  0.489
2011 Nuechterlein KH, Subotnik KL, Green MF, Ventura J, Asarnow RF, Gitlin MJ, Yee CM, Gretchen-Doorly D, Mintz J. Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophrenia Bulletin. 37: S33-40. PMID 21860045 DOI: 10.1093/Schbul/Sbr084  0.608
2011 Bartzokis G, Lu PH, Amar CP, Raven EP, Detore NR, Altshuler LL, Mintz J, Ventura J, Casaus LR, Luo JS, Subotnik KL, Nuechterlein KH. Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory. Schizophrenia Research. 132: 35-41. PMID 21767934 DOI: 10.1016/J.Schres.2011.06.029  0.336
2011 Ventura J, Subotnik KL, Guzik LH, Hellemann GS, Gitlin MJ, Wood RC, Nuechterlein KH. Remission and recovery during the first outpatient year of the early course of schizophrenia. Schizophrenia Research. 132: 18-23. PMID 21764563 DOI: 10.1016/J.Schres.2011.06.025  0.382
2011 Phillips OR, Nuechterlein KH, Asarnow RF, Clark KA, Cabeen R, Yang Y, Woods RP, Toga AW, Narr KL. Mapping corticocortical structural integrity in schizophrenia and effects of genetic liability. Biological Psychiatry. 70: 680-9. PMID 21571255 DOI: 10.1016/J.Biopsych.2011.03.039  0.465
2011 Mathis KI, Wynn JK, Breitmeyer B, Nuechterlein KH, Green MF. The attentional blink in schizophrenia: isolating the perception/attention interface. Journal of Psychiatric Research. 45: 1346-51. PMID 21550051 DOI: 10.1016/J.Jpsychires.2011.04.002  0.839
2011 Carter CS, Barch DM, Bullmore E, Breiling J, Buchanan RW, Butler P, Cohen JD, Geyer M, Gollub R, Green MF, Jaeger J, Krystal JH, Moore H, Nuechterlein K, Robbins T, et al. Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders. Biological Psychiatry. 70: 7-12. PMID 21529781 DOI: 10.1016/J.Biopsych.2011.01.041  0.594
2011 Greenwood TA, Lazzeroni LC, Murray SS, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Gur RE, Gur RC, Hardiman G, Kelsoe JR, Leonard S, Light GA, Nuechterlein KH, Olincy A, et al. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. The American Journal of Psychiatry. 168: 930-46. PMID 21498463 DOI: 10.1176/Appi.Ajp.2011.10050723  0.54
2011 Reise SP, Ventura J, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder R. Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia. Psychological Assessment. 23: 245-61. PMID 21381848 DOI: 10.1037/A0021501  0.538
2011 Clark KA, Nuechterlein KH, Asarnow RF, Hamilton LS, Phillips OR, Hageman NS, Woods RP, Alger JR, Toga AW, Narr KL. Mean diffusivity and fractional anisotropy as indicators of disease and genetic liability to schizophrenia. Journal of Psychiatric Research. 45: 980-8. PMID 21306734 DOI: 10.1016/J.Jpsychires.2011.01.006  0.443
2011 Masten AS, Nuechterlein KH, Wright MO. Norman Garmezy (1918-2009). The American Psychologist. 66: 140-1. PMID 21299255 DOI: 10.1037/A0021246  0.481
2011 Stone WS, Giuliano AJ, Tsuang MT, Braff DL, Cadenhead KS, Calkins ME, Dobie DJ, Faraone SV, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, ... Nuechterlein KH, et al. Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 128: 102-10. PMID 21288694 DOI: 10.1016/J.Schres.2011.01.005  0.594
2011 Subotnik KL, Nuechterlein KH, Ventura J, Gitlin MJ, Marder S, Mintz J, Hellemann GS, Thornton LA, Singh IR. Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia. The American Journal of Psychiatry. 168: 286-92. PMID 21205805 DOI: 10.1176/Appi.Ajp.2010.09010087  0.396
2011 Harvey PO, Lee J, Cohen MS, Engel SA, Glahn DC, Nuechterlein KH, Wynn JK, Green MF. Altered dynamic coupling of lateral occipital complex during visual perception in schizophrenia. Neuroimage. 55: 1219-26. PMID 21194569 DOI: 10.1016/J.Neuroimage.2010.12.045  0.555
2011 Kern RS, Gold JM, Dickinson D, Green MF, Nuechterlein KH, Baade LE, Keefe RS, Mesholam-Gately RI, Seidman LJ, Lee C, Sugar CA, Marder SR. The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophrenia Research. 126: 124-31. PMID 21159492 DOI: 10.1016/J.Schres.2010.11.008  0.581
2011 Green MF, Wynn JK, Breitmeyer B, Mathis KI, Nuechterlein KH. Visual masking by object substitution in schizophrenia. Psychological Medicine. 41: 1489-96. PMID 21078224 DOI: 10.1017/S003329171000214X  0.84
2011 Williams TJ, Nuechterlein KH, Subotnik KL, Yee CM. Distinct neural generators of sensory gating in schizophrenia. Psychophysiology. 48: 470-8. PMID 20735757 DOI: 10.1111/j.1469-8986.2010.01119.x  0.833
2010 Yang Y, Nuechterlein KH, Phillips O, Hamilton LS, Subotnik KL, Asarnow RF, Toga AW, Narr KL. The contributions of disease and genetic factors towards regional cortical thinning in schizophrenia: the UCLA family study. Schizophrenia Research. 123: 116-25. PMID 20817413 DOI: 10.1016/J.Schres.2010.08.005  0.412
2010 Dawson ME, Schell AM, Rissling A, Ventura J, Subotnik KL, Nuechterlein KH. Psychophysiological prodromal signs of schizophrenic relapse: a pilot study. Schizophrenia Research. 123: 64-7. PMID 20724111 DOI: 10.1016/J.Schres.2010.07.029  0.447
2010 Harvey PD, Green MF, Nuechterlein KH. Latest developments in the matrics process. Psychiatry (Edgmont (Pa. : Township)). 7: 49-52. PMID 20622946  0.511
2010 Ventura J, Reise SP, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder RM. The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition. Schizophrenia Research. 121: 24-31. PMID 20542412 DOI: 10.1016/J.Schres.2010.04.016  0.525
2010 Lee J, Cohen MS, Engel SA, Glahn D, Nuechterlein KH, Wynn JK, Green MF. Regional brain activity during early visual perception in unaffected siblings of schizophrenia patients. Biological Psychiatry. 68: 78-85. PMID 20494338 DOI: 10.1016/J.Biopsych.2010.03.028  0.531
2010 Olincy A, Braff DL, Adler LE, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, et al. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophrenia Research. 119: 175-82. PMID 20382002 DOI: 10.1016/J.Schres.2010.03.004  0.583
2010 Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Meichle SP, Millard SP, Mintz J, ... Nuechterlein KH, et al. Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology. 47: 846-56. PMID 20374545 DOI: 10.1111/J.1469-8986.2010.01004.X  0.616
2010 Yee CM, Mathis KI, Sun JC, Sholty GL, Lang PJ, Bachman P, Williams TJ, Bearden CE, Cannon TD, Green MF, Subotnik KL, Ventura J, Nuechterlein KH. Integrity of emotional and motivational states during the prodromal, first-episode, and chronic phases of schizophrenia. Journal of Abnormal Psychology. 119: 71-82. PMID 20141244 DOI: 10.1037/A0018475  0.774
2010 Yee CM, Williams TJ, White PM, Nuechterlein KH, Ames D, Subotnik KL. Attentional modulation of the P50 suppression deficit in recent-onset and chronic schizophrenia. Journal of Abnormal Psychology. 119: 31-9. PMID 20141240 DOI: 10.1037/a0018265  0.852
2010 Fogelson DL, Asarnow RA, Sugar CA, Subotnik KL, Jacobson KC, Neale MC, Kendler KS, Kuppinger H, Nuechterlein KH. Avoidant personality disorder symptoms in first-degree relatives of schizophrenia patients predict performance on neurocognitive measures: the UCLA family study. Schizophrenia Research. 120: 113-20. PMID 20053537 DOI: 10.1016/j.schres.2009.12.004  0.409
2010 Nuechterlein K. Successful Return To Work Or School In Recent-Onset Schizophrenia: The Ucla Randomized Controlled Trial Of Individual Placement And Support Schizophrenia Research. 117: 133-133. DOI: 10.1016/J.Schres.2010.02.091  0.461
2010 Nuechterlein KH, Green MF, Kern RS. Schizophrenia as a cognitive disorder: Recent approaches to identifying its core cognitive components to aid treatment development Advances in Schizophrenia Research 2009. 267-282. DOI: 10.1007/978-1-4419-0913-8_14  0.547
2009 Green MF, Lee J, Cohen MS, Engel SA, Korb AS, Nuechterlein KH, Wynn JK, Glahn DC. Functional neuroanatomy of visual masking deficits in schizophrenia. Archives of General Psychiatry. 66: 1295-303. PMID 19996034 DOI: 10.1001/Archgenpsychiatry.2009.132  0.543
2009 Hans SL, Auerbach JG, Nuechterlein KH, Asarnow RF, Asarnow J, Styr B, Marcus J. Neurodevelopmental factors associated with schizotypal symptoms among adolescents at risk for schizophrenia. Development and Psychopathology. 21: 1195-210. PMID 19825264 DOI: 10.1017/S0954579409990113  0.414
2009 Sun D, van Erp TG, Thompson PM, Bearden CE, Daley M, Kushan L, Hardt ME, Nuechterlein KH, Toga AW, Cannon TD. Elucidating a magnetic resonance imaging-based neuroanatomic biomarker for psychosis: classification analysis using probabilistic brain atlas and machine learning algorithms. Biological Psychiatry. 66: 1055-60. PMID 19729150 DOI: 10.1016/J.Biopsych.2009.07.019  0.477
2009 Sanz JH, Karlsgodt KH, Bearden CE, van Erp TG, Nandy RR, Ventura J, Nuechterlein K, Cannon TD. Symptomatic and functional correlates of regional brain physiology during working memory processing in patients with recent onset schizophrenia. Psychiatry Research. 173: 177-82. PMID 19692211 DOI: 10.1016/J.Pscychresns.2009.02.008  0.612
2009 Bartzokis G, Lu PH, Stewart SB, Oluwadara B, Lucas AJ, Pantages J, Pratt E, Sherin JE, Altshuler LL, Mintz J, Gitlin MJ, Subotnik KL, Nuechterlein KH. In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia. Schizophrenia Research. 113: 322-31. PMID 19616412 DOI: 10.1016/J.Schres.2009.06.014  0.383
2009 Hamilton LS, Altshuler LL, Townsend J, Bookheimer SY, Phillips OR, Fischer J, Woods RP, Mazziotta JC, Toga AW, Nuechterlein KH, Narr KL. Alterations in functional activation in euthymic bipolar disorder and schizophrenia during a working memory task. Human Brain Mapping. 30: 3958-69. PMID 19449330 DOI: 10.1002/Hbm.20820  0.477
2009 Karlsgodt KH, Sanz J, van Erp TG, Bearden CE, Nuechterlein KH, Cannon TD. Re-evaluating dorsolateral prefrontal cortex activation during working memory in schizophrenia. Schizophrenia Research. 108: 143-50. PMID 19196494 DOI: 10.1016/J.Schres.2008.12.025  0.545
2009 Sergi MJ, Fiske AP, Horan WP, Kern RS, Kee KS, Subotnik KL, Nuechterlein KH, Green MF. Development of a measure of relationship perception in schizophrenia. Psychiatry Research. 166: 54-62. PMID 19193447 DOI: 10.1016/J.Psychres.2008.03.010  0.61
2009 Narr KL, Hageman N, Woods RP, Hamilton LS, Clark K, Phillips O, Shattuck DW, Asarnow RF, Toga AW, Nuechterlein KH. Mean diffusivity: a biomarker for CSF-related disease and genetic liability effects in schizophrenia. Psychiatry Research. 171: 20-32. PMID 19081707 DOI: 10.1016/J.Pscychresns.2008.03.008  0.405
2009 Nuechterlein KH, Luck SJ, Lustig C, Sarter M. CNTRICS final task selection: control of attention. Schizophrenia Bulletin. 35: 182-96. PMID 19074499 DOI: 10.1093/schbul/sbn158  0.418
2009 Phillips OR, Nuechterlein KH, Clark KA, Hamilton LS, Asarnow RF, Hageman NS, Toga AW, Narr KL. Fiber tractography reveals disruption of temporal lobe white matter tracts in schizophrenia. Schizophrenia Research. 107: 30-8. PMID 19028423 DOI: 10.1016/J.Schres.2008.10.019  0.378
2009 Barch DM, Carter CS, Arnsten A, Buchanan RW, Cohen JD, Geyer M, Green MF, Krystal JH, Nuechterlein K, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R. Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophrenia Bulletin. 35: 109-14. PMID 19023126 DOI: 10.1093/Schbul/Sbn163  0.531
2009 Kee KS, Horan WP, Salovey P, Kern RS, Sergi MJ, Fiske AP, Lee J, Subotnik KL, Nuechterlein K, Sugar CA, Green MF. Emotional intelligence in schizophrenia. Schizophrenia Research. 107: 61-8. PMID 18805674 DOI: 10.1016/J.Schres.2008.08.016  0.623
2009 Kern RS, Green MF, Fiske AP, Kee KS, Lee J, Sergi MJ, Horan WP, Subotnik KL, Sugar CA, Nuechterlein KH. Theory of mind deficits for processing counterfactual information in persons with chronic schizophrenia. Psychological Medicine. 39: 645-54. PMID 18694537 DOI: 10.1017/S0033291708003966  0.58
2009 Horan WP, Nuechterlein KH, Wynn JK, Lee J, Castelli F, Green MF. Disturbances in the spontaneous attribution of social meaning in schizophrenia. Psychological Medicine. 39: 635-43. PMID 18606048 DOI: 10.1017/S0033291708003838  0.554
2008 Wynn JK, Green MF, Engel S, Korb A, Lee J, Glahn D, Nuechterlein KH, Cohen MS. Increased extent of object-selective cortex in schizophrenia. Psychiatry Research. 164: 97-105. PMID 18938066 DOI: 10.1016/J.Pscychresns.2008.01.005  0.599
2008 Horan WP, Green MF, Knowlton BJ, Wynn JK, Mintz J, Nuechterlein KH. Impaired implicit learning in schizophrenia. Neuropsychology. 22: 606-17. PMID 18763880 DOI: 10.1037/A0012602  0.458
2008 Turetsky BI, Greenwood TA, Olincy A, Radant AD, Braff DL, Cadenhead KS, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Schork NJ, et al. Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biological Psychiatry. 64: 1051-9. PMID 18701089 DOI: 10.1016/J.Biopsych.2008.06.018  0.583
2008 Kerns JG, Nuechterlein KH, Braver TS, Barch DM. Executive functioning component mechanisms and schizophrenia. Biological Psychiatry. 64: 26-33. PMID 18549874 DOI: 10.1016/j.biopsych.2008.04.027  0.483
2008 Carter CS, Barch DM, Buchanan RW, Bullmore E, Krystal JH, Cohen J, Geyer M, Green M, Nuechterlein KH, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R. Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biological Psychiatry. 64: 4-10. PMID 18466880 DOI: 10.1016/J.Biopsych.2008.03.020  0.557
2008 Lee J, Nuechterlein KH, Subotnik KL, Sugar CA, Ventura J, Gretchen-Doorly D, Kelly K, Green MF. Stability of visual masking performance in recent-onset schizophrenia: an 18-month longitudinal study. Schizophrenia Research. 103: 266-74. PMID 18450427 DOI: 10.1016/J.Schres.2008.03.005  0.623
2008 Horan WP, Braff DL, Nuechterlein KH, Sugar CA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Olincy A, Radant AD, et al. Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophrenia Research. 103: 218-28. PMID 18406578 DOI: 10.1016/J.Schres.2008.02.014  0.625
2008 Hazlett EA, Dawson ME, Schell AM, Nuechterlein KH. Probing attentional dysfunctions in schizophrenia: Startle modification during a continuous performance test. Psychophysiology. 45: 632-42. PMID 18282203 DOI: 10.1111/j.1469-8986.2008.00653.x  0.328
2008 Horan WP, Reise SP, Subotnik KL, Ventura J, Nuechterlein KH. The validity of Psychosis Proneness Scales as vulnerability indicators in recent-onset schizophrenia patients. Schizophrenia Research. 100: 224-36. PMID 18221857 DOI: 10.1016/J.Schres.2007.12.469  0.394
2008 Foerde K, Poldrack RA, Khan BJ, Sabb FW, Bookheimer SY, Bilder RM, Guthrie D, Granholm E, Nuechterlein KH, Marder SR, Asarnow RF. Selective corticostriatal dysfunction in schizophrenia: examination of motor and cognitive skill learning. Neuropsychology. 22: 100-9. PMID 18211159 DOI: 10.1037/0894-4105.22.1.100  0.425
2008 Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. The American Journal of Psychiatry. 165: 203-13. PMID 18172019 DOI: 10.1176/Appi.Ajp.2007.07010042  0.557
2008 Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Mintz J, Seidman LJ, Stover E, Marder SR. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. The American Journal of Psychiatry. 165: 214-20. PMID 18172018 DOI: 10.1176/Appi.Ajp.2007.07010043  0.469
2008 Green MF, Nuechterlein KH, Kern RS, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Seidman LJ, Stover E, Marder SR. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. The American Journal of Psychiatry. 165: 221-8. PMID 18172017 DOI: 10.1176/Appi.Ajp.2007.07010089  0.499
2008 van Erp TG, Lesh TA, Knowlton BJ, Bearden CE, Hardt M, Karlsgodt KH, Shirinyan D, Rao V, Green MF, Subotnik KL, Nuechterlein K, Cannon TD. Remember and know judgments during recognition in chronic schizophrenia. Schizophrenia Research. 100: 181-90. PMID 17964760 DOI: 10.1016/J.Schres.2007.09.021  0.717
2008 Karlsgodt KH, van Erp TG, Poldrack RA, Bearden CE, Nuechterlein KH, Cannon TD. Diffusion tensor imaging of the superior longitudinal fasciculus and working memory in recent-onset schizophrenia. Biological Psychiatry. 63: 512-8. PMID 17720147 DOI: 10.1016/j.biopsych.2007.06.017  0.649
2008 Nuechterlein K, Pashler H, Subotnik K, Green M, Cannon T, Bearden C. TRANSLATIONAL RESEARCH TO PROBE ATTENTIONAL DEFICITS IN SCHIZOPHRENIA: DUAL-TASK INTERFERENCE IN PRODROMAL, FIRST EPISODE, AND CHRONIC PHASES OF SCHIZOPHRENIA Schizophrenia Research. 102: 124. DOI: 10.1016/S0920-9964(08)70376-1  0.731
2008 Nuechterlein K, Subotnik K, Ventura J, Gitlin M, Gretchen-Doorly D, Green M, Becker D, Drake R, Mintz J, Wallace C, Liberman R. A Randomized Controlled Trial Of Supported Employment And Education And Workplace Skills Training In Recent-Onset Schizophrenia: Notable Improvements In Work Recovery Schizophrenia Research. 102: 28. DOI: 10.1016/S0920-9964(08)70089-6  0.546
2008 Braff DL, Greenwood TA, Swerdlow NR, Light GA, Schork NJ, Calkins ME, Gur RE, Gur RC, Turetsky BI, Dobie DJ, Radant AD, Tsuang DW, Freedman R, Olincy A, Cadenhead KS, ... ... Nuechterlein KH, et al. Advances in endophenotyping schizophrenia World Psychiatry. 7: 11-18.  0.491
2007 Greenwood TA, Braff DL, Light GA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, et al. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Archives of General Psychiatry. 64: 1242-50. PMID 17984393 DOI: 10.1001/Archpsyc.64.11.1242  0.565
2007 Bartzokis G, Lu PH, Nuechterlein KH, Gitlin M, Doi C, Edwards N, Lieu C, Altshuler LL, Mintz J. Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophrenia Research. 93: 13-22. PMID 17407804 DOI: 10.1016/J.Schres.2007.02.011  0.442
2007 Swerdlow NR, Sprock J, Light GA, Cadenhead K, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Mintz J, Olincy A, Nuechterlein KH, Radant AD, Schork NJ, et al. Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophrenia Research. 92: 237-51. PMID 17346930 DOI: 10.1016/J.Schres.2007.01.012  0.46
2007 Gur RE, Calkins ME, Gur RC, Horan WP, Nuechterlein KH, Seidman LJ, Stone WS. The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. Schizophrenia Bulletin. 33: 49-68. PMID 17101692 DOI: 10.1093/Schbul/Sbl055  0.403
2007 Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, et al. The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophrenia Bulletin. 33: 33-48. PMID 17035358 DOI: 10.1093/Schbul/Sbl044  0.519
2007 Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Light GA, Meichle SP, Mintz J, Nuechterlein KH, Schork NJ, et al. Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophrenia Research. 89: 320-9. PMID 17023145 DOI: 10.1016/J.Schres.2006.08.010  0.583
2006 Nuechterlein KH, Pashler HE, Subotnik KL. Translating basic attentional paradigms to schizophrenia research: reconsidering the nature of the deficits. Development and Psychopathology. 18: 831-51. PMID 17152403 DOI: 10.1017/S095457940606041X  0.556
2006 Nuechterlein KH, Miklowitz DJ, Ventura J, Gitlin MJ, Stoddard M, Lukoff D. Classifying episodes in schizophrenia and bipolar disorder: criteria for relapse and remission applied to recent-onset samples. Psychiatry Research. 144: 153-66. PMID 17011635 DOI: 10.1016/J.Psychres.2004.04.018  0.43
2006 Wynn JK, Breitmeyer B, Nuechterlein KH, Green MF. Exploring the short term visual store in schizophrenia using the attentional blink. Journal of Psychiatric Research. 40: 599-605. PMID 16890242 DOI: 10.1016/J.Jpsychires.2006.06.002  0.595
2006 Horan WP, Green MF, Kring AM, Nuechterlein KH. Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions? Journal of Abnormal Psychology. 115: 496-508. PMID 16866590 DOI: 10.1037/0021-843X.115.3.496  0.548
2006 Morris SE, Yee CM, Nuechterlein KH. Electrophysiological analysis of error monitoring in schizophrenia. Journal of Abnormal Psychology. 115: 239-50. PMID 16737389 DOI: 10.1037/0021-843X.115.2.239  0.665
2006 Subotnik KL, Nuechterlein KH, Green MF, Horan WP, Nienow TM, Ventura J, Nguyen AT. Neurocognitive and social cognitive correlates of formal thought disorder in schizophrenia patients. Schizophrenia Research. 85: 84-95. PMID 16624529 DOI: 10.1016/J.Schres.2006.03.007  0.551
2006 Niendam TA, Bearden CE, Johnson JK, McKinley M, Loewy R, O'Brien M, Nuechterlein KH, Green MF, Cannon TD. Neurocognitive performance and functional disability in the psychosis prodrome. Schizophrenia Research. 84: 100-11. PMID 16563699 DOI: 10.1016/J.Schres.2006.02.005  0.609
2006 Sergi MJ, Rassovsky Y, Nuechterlein KH, Green MF. Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia. The American Journal of Psychiatry. 163: 448-54. PMID 16513866 DOI: 10.1176/Appi.Ajp.163.3.448  0.554
2006 Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. Forward and backward visual masking in unaffected siblings of schizophrenic patients. Biological Psychiatry. 59: 446-51. PMID 16139818 DOI: 10.1016/J.Biopsych.2005.06.035  0.432
2006 Alarcon E, Gretchen-Doorly D, Nuechterlein K, Subotnik K. 355 Development Of An Outpatient Healthy Behavior Program For Recent-Onset Schizophrenia Patients. Journal of Investigative Medicine. 54. DOI: 10.2310/6650.2005.X0004.354  0.468
2005 Wynn JK, Light GA, Breitmeyer B, Nuechterlein KH, Green MF. Event-related gamma activity in schizophrenia patients during a visual backward-masking task. The American Journal of Psychiatry. 162: 2330-6. PMID 16330598 DOI: 10.1176/Appi.Ajp.162.12.2330  0.594
2005 Cannon TD, Glahn DC, Kim J, Van Erp TG, Karlsgodt K, Cohen MS, Nuechterlein KH, Bava S, Shirinyan D. Dorsolateral prefrontal cortex activity during maintenance and manipulation of information in working memory in patients with schizophrenia. Archives of General Psychiatry. 62: 1071-80. PMID 16203952 DOI: 10.1001/archpsyc.62.10.1071  0.677
2005 Nuechterlein KH, Robbins TW, Einat H. Distinguishing separable domains of cognition in human and animal studies: what separations are optimal for targeting interventions? A summary of recommendations from breakout group 2 at the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophrenia Bulletin. 31: 870-4. PMID 16150960 DOI: 10.1093/schbul/sbi047  0.358
2005 Rassovsky Y, Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. Modulation of attention during visual masking in schizophrenia. The American Journal of Psychiatry. 162: 1533-5. PMID 16055778 DOI: 10.1176/Appi.Ajp.162.8.1533  0.609
2005 Horan WP, Subotnik KL, Reise SP, Ventura J, Nuechterlein KH. Stability and clinical correlates of personality characteristics in recent-onset schizophrenia. Psychological Medicine. 35: 995-1005. PMID 16045066 DOI: 10.1017/S003329170500440X  0.392
2005 Schell AM, Dawson ME, Rissling A, Ventura J, Subotnik KL, Gitlin MJ, Nuechterlein KH. Electrodermal predictors of functional outcome and negative symptoms in schizophrenia. Psychophysiology. 42: 483-92. PMID 16008777 DOI: 10.1111/J.1469-8986.2005.00300.X  0.406
2005 Rassovsky Y, Green MF, Nuechterlein KH, Breitmeyer BG, Mintz J. Visual processing in schizophrenia: Structural equation modeling of visual masking performance. Schizophrenia Research. 78: 251-60. PMID 15975768 DOI: 10.1016/J.Schres.2005.05.011  0.469
2005 Buchanan RW, Davis M, Goff D, Green MF, Keefe RS, Leon AC, Nuechterlein KH, Laughren T, Levin R, Stover E, Fenton W, Marder SR. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophrenia Bulletin. 31: 5-19. PMID 15888422 DOI: 10.1093/Schbul/Sbi020  0.474
2005 Horan WP, Ventura J, Nuechterlein KH, Subotnik KL, Hwang SS, Mintz J. Stressful life events in recent-onset schizophrenia: reduced frequencies and altered subjective appraisals. Schizophrenia Research. 75: 363-74. PMID 15885527 DOI: 10.1016/J.Schres.2004.07.019  0.372
2005 Subotnik KL, Nuechterlein KH, Irzhevsky V, Kitchen CM, Woo SM, Mintz J. Is unawareness of psychotic disorder a neurocognitive or psychological defensiveness problem? Schizophrenia Research. 75: 147-57. PMID 15885506 DOI: 10.1016/j.schres.2004.12.005  0.324
2005 Green MF, Glahn D, Engel SA, Nuechterlein KH, Sabb F, Strojwas M, Cohen MS. Regional brain activity associated with visual backward masking. Journal of Cognitive Neuroscience. 17: 13-23. PMID 15701236 DOI: 10.1162/0898929052880011  0.342
2005 Subotnik KL, Asarnow RF, Nuechterlein KH, Fogelson DL, Thorpe TI, Payne DL, Giannini CA, Kuppinger HE, Torquato RD, Mintz J, Hwang SS, Gottesman II. MMPI vulnerability indicators for schizophrenia and attention deficit disorder: UCLA family study of biological parents of offspring with childhood-onset schizophrenia or ADHD. Behavior Genetics. 35: 159-75. PMID 15685429 DOI: 10.1007/S10519-004-1016-7  0.346
2005 Shurman B, Horan WP, Nuechterlein KH. Schizophrenia patients demonstrate a distinctive pattern of decision-making impairment on the Iowa Gambling Task. Schizophrenia Research. 72: 215-24. PMID 15560966 DOI: 10.1016/J.Schres.2004.03.020  0.423
2004 Wiedl KH, Schöttke H, Green MF, Nuechterlein KH. Dynamic testing in schizophrenia: does training change the construct validity of a test? Schizophrenia Bulletin. 30: 703-11. PMID 15954185 DOI: 10.1093/Oxfordjournals.Schbul.A007124  0.422
2004 Woo SM, Goldstein MJ, Nuechterlein KH. Relatives' affective style and the expression of subclinical psychopathology in patients with schizophrenia. Family Process. 43: 233-47. PMID 15603506 DOI: 10.1111/J.1545-5300.2004.04302008.X  0.338
2004 Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophrenia Research. 72: 29-39. PMID 15531405 DOI: 10.1016/J.Schres.2004.09.007  0.592
2004 Kern RS, Green MF, Nuechterlein KH, Deng BH. NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophrenia Research. 72: 11-9. PMID 15531403 DOI: 10.1016/J.Schres.2004.09.004  0.523
2004 Green MF, Nuechterlein KH. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophrenia Research. 72: 1-3. PMID 15531401 DOI: 10.1016/J.Schres.2004.09.006  0.615
2004 Rassovsky Y, Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. Paracontrast and metacontrast in schizophrenia: clarifying the mechanism for visual masking deficits. Schizophrenia Research. 71: 485-92. PMID 15474919 DOI: 10.1016/J.Schres.2004.02.018  0.521
2004 Ventura J, Nuechterlein KH, Subotnik KL, Green MF, Gitlin MJ. Self-efficacy and neurocognition may be related to coping responses in recent-onset schizophrenia. Schizophrenia Research. 69: 343-52. PMID 15469206 DOI: 10.1016/J.Schres.2003.09.002  0.611
2004 Ventura J, Nuechterlein KH, Green MF, Horan WP, Subotnik KL, Mintz J. The timing of negative symptom exacerbations in relationship to positive symptom exacerbations in the early course of schizophrenia. Schizophrenia Research. 69: 333-42. PMID 15469205 DOI: 10.1016/S0920-9964(03)00096-3  0.464
2004 Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry. 56: 301-7. PMID 15336511 DOI: 10.1016/J.Biopsych.2004.06.023  0.568
2004 Fogelson DL, Nuechterlein KH, Asarnow RF, Payne DL, Subotnik KL. Validity of the family history method for diagnosing schizophrenia, schizophrenia-related psychoses, and schizophrenia-spectrum personality disorders in first-degree relatives of schizophrenia probands. Schizophrenia Research. 68: 309-17. PMID 15099612 DOI: 10.1016/S0920-9964(03)00081-1  0.423
2004 Kim J, Glahn DC, Nuechterlein KH, Cannon TD. Maintenance and manipulation of information in schizophrenia: further evidence for impairment in the central executive component of working memory. Schizophrenia Research. 68: 173-87. PMID 15099601 DOI: 10.1016/S0920-9964(03)00150-6  0.701
2003 Subotnik KL, Bartzokis G, Green MF, Nuechterlein KH. Neuroanatomical correlates of formal thought disorder in schizophrenia. Cognitive Neuropsychiatry. 8: 81-8. PMID 16571552 DOI: 10.1080/13546800244000148  0.457
2003 Niendam TA, Bearden CE, Rosso IM, Sanchez LE, Hadley T, Nuechterlein KH, Cannon TD. A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. The American Journal of Psychiatry. 160: 2060-2. PMID 14594759 DOI: 10.1176/Appi.Ajp.160.11.2060  0.602
2003 Green MF, Nuechterlein KH, Breitmeyer B, Tsuang J, Mintz J. Forward and backward visual masking in schizophrenia: influence of age. Psychological Medicine. 33: 887-95. PMID 12877403 DOI: 10.1017/S003329170200716X  0.59
2003 Green MF, Mintz J, Salveson D, Nuechterlein KH, Breitmeyer B, Light GA, Braff DL. Visual masking as a probe for abnormal gamma range activity in schizophrenia. Biological Psychiatry. 53: 1113-9. PMID 12814862 DOI: 10.1016/S0006-3223(02)01813-9  0.568
2003 Bartzokis G, Nuechterlein KH, Lu PH, Gitlin M, Rogers S, Mintz J. Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biological Psychiatry. 53: 412-21. PMID 12614994 DOI: 10.1016/S0006-3223(02)01835-8  0.326
2003 Niendam T, Bearden C, Rosso I, Sanchez L, Hadley T, Nuechterlein K, Cannon T. Assessment of neurocognitive decline in the premorbid period of schizophrenia Schizophrenia Research. 60: 151. DOI: 10.1016/S0920-9964(03)80977-5  0.679
2002 Subotnik KL, Goldstein MJ, Nuechterlein KH, Woo SM, Mintz J. Are communication deviance and expressed emotion related to family history of psychiatric disorders in schizophrenia? Schizophrenia Bulletin. 28: 719-29. PMID 12795501 DOI: 10.1093/Oxfordjournals.Schbul.A006975  0.355
2002 Green MF, Nuechterlein KH, Breitmeyer B. Development of a computerized assessment for visual masking. International Journal of Methods in Psychiatric Research. 11: 83-9. PMID 12459798 DOI: 10.1002/Mpr.126  0.465
2002 Schell AM, Dawson ME, Nuechterlein KH, Subotnik KL, Ventura J. The temporal stability of electrodermal variables over a one-year period in patients with recent-onset schizophrenia and in normal subjects. Psychophysiology. 39: 124-32. PMID 12212661 DOI: 10.1017/S0048577202010193  0.313
2002 Nuechterlein KH, Asarnow RF, Subotnik KL, Fogelson DL, Payne DL, Kendler KS, Neale MC, Jacobson KC, Mintz J. The structure of schizotypy: relationships between neurocognitive and personality disorder features in relatives of schizophrenic patients in the UCLA Family Study. Schizophrenia Research. 54: 121-30. PMID 11853986 DOI: 10.1016/S0920-9964(01)00359-0  0.383
2002 Asarnow RF, Nuechterlein KH, Asamen J, Fogelson D, Subotnik KL, Zaucha K, Guthrie D. Neurocognitive functioning and schizophrenia spectrum disorders can be independent expressions of familial liability for schizophrenia in community control children: the UCLA family study. Schizophrenia Research. 54: 111-20. PMID 11853985 DOI: 10.1016/S0920-9964(01)00358-9  0.484
2001 Wiedl KH, Wienöbst J, Schöttke HH, Green MF, Nuechterlein KH. Attentional characteristics of schizophrenia patients differing in learning proficiency on the Wisconsin Card Sorting Test. Schizophrenia Bulletin. 27: 687-95. PMID 11824494 DOI: 10.1093/Oxfordjournals.Schbul.A006907  0.524
2001 Gitlin M, Nuechterlein K, Subotnik KL, Ventura J, Mintz J, Fogelson DL, Bartzokis G, Aravagiri M. Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. The American Journal of Psychiatry. 158: 1835-42. PMID 11691689 DOI: 10.1176/Appi.Ajp.158.11.1835  0.474
2001 Asarnow RF, Nuechterlein KH, Fogelson D, Subotnik KL, Payne DA, Russell AT, Asamen J, Kuppinger H, Kendler KS. Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: the UCLA family study. Archives of General Psychiatry. 58: 581-8. PMID 11386988 DOI: 10.1001/Archpsyc.58.6.581  0.387
2000 Rosenfarb IS, Nuechterlein KH, Goldstein MJ, Subotnik KL. Neurocognitive vulnerability, interpersonal criticism, and the emergence of unusual thinking by schizophrenic patients during family transactions. Archives of General Psychiatry. 57: 1174-9. PMID 11115332 DOI: 10.1001/Archpsyc.57.12.1174  0.314
2000 Weisman AG, López SR, Ventura J, Nuechterlein KH, Goldstein MJ, Hwang S. A comparison of psychiatric symptoms between Anglo-Americans and Mexican-Americans with schizophrenia. Schizophrenia Bulletin. 26: 817-24. PMID 11087014 DOI: 10.1093/Oxfordjournals.Schbul.A033496  0.356
2000 Dawson ME, Schell AM, Hazlett EA, Nuechterlein KH, Filion DL. On the clinical and cognitive meaning of impaired sensorimotor gating in schizophrenia. Psychiatry Research. 96: 187-97. PMID 11084215 DOI: 10.1016/S0165-1781(00)00208-0  0.521
2000 Gitlin MJ, Nuechterlein KH, Mintz J, Fogelson D, Bartzokis G, Ventura J, Subotnik K, Aravagiri M. Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects, psychosocial function and depression. Psychopharmacology. 148: 350-4. PMID 10928306 DOI: 10.1007/S002130050062  0.336
2000 Subotnik KL, Nuechterlein KH, Ventura J. MMPI discriminators of deficit vs. non-deficit recent-onset schizophrenia patients. Psychiatry Research. 93: 111-23. PMID 10725528 DOI: 10.1016/S0165-1781(00)00102-5  0.475
1999 Green MF, Nuechterlein KH. Cortical oscillations and schizophrenia: timing is of the essence. Archives of General Psychiatry. 56: 1007-8. PMID 10565500 DOI: 10.1001/Archpsyc.56.11.1007  0.563
1999 Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. Backward masking in unmedicated schizophrenic patients in psychotic remission: possible reflection of aberrant cortical oscillation. The American Journal of Psychiatry. 156: 1367-73. PMID 10484946 DOI: 10.1176/Ajp.156.9.1367  0.584
1999 Hans SL, Marcus J, Nuechterlein KH, Asarnow RF, Styr B, Auerbach JG. Neurobehavioral deficits at adolescence in children at risk for schizophrenia: The Jerusalem Infant Development Study. Archives of General Psychiatry. 56: 741-8. PMID 10435609 DOI: 10.1001/archpsyc.56.8.741  0.305
1999 Green MF, Nuechterlein KH. Should schizophrenia be treated as a neurocognitive disorder? Schizophrenia Bulletin. 25: 309-19. PMID 10416733 DOI: 10.1093/Oxfordjournals.Schbul.A033380  0.586
1999 Subotnik KL, Nuechterlein KH, Green MF. Trait versus state aspects of the MMPI during the early course of schizophrenia. Journal of Psychiatric Research. 33: 275-84. PMID 10367994 DOI: 10.1016/S0022-3956(98)00062-4  0.546
1999 Strandburg RJ, Marsh JT, Brown WS, Asarnow RF, Guthrie D, Harper R, Nuechterlein KH. Continuous-processing related ERPS in adult schizophrenia: continuity with childhood onset schizophrenia. Biological Psychiatry. 45: 1356-69. PMID 10349042 DOI: 10.1016/S0006-3223(98)00349-7  0.411
1999 Green MF, Nuechterlein KH. Backward masking performance as an indicator of vulnerability to schizophrenia. Acta Psychiatrica Scandinavica. Supplementum. 395: 34-40. PMID 10225331 DOI: 10.1111/J.1600-0447.1999.Tb05981.X  0.642
1998 Yee CM, Nuechterlein KH, Morris SE, White PM. P50 suppression in recent-onset schizophrenia: clinical correlates and risperidone effects. Journal of Abnormal Psychology. 107: 691-8. PMID 9830258 DOI: 10.1037//0021-843X.107.4.691  0.758
1998 Subotnik KL, Nuechterlein KH, Ventura J, Green MF, Hwang SS. Prediction of the deficit syndrome from initial deficit symptoms in the early course of schizophrenia. Psychiatry Research. 80: 53-9. PMID 9727963 DOI: 10.1016/S0165-1781(98)00052-3  0.529
1998 Yee CM, Nuechterlein KH, Dawson ME. A longitudinal analysis of eye tracking dysfunction and attention in recent-onset schizophrenia. Psychophysiology. 35: 443-51. PMID 9643059 DOI: 10.1017/S0048577298961285  0.354
1997 Strandburg RJ, Marsh JT, Brown WS, Asarnow RF, Guthrie D, Harper R, Yee CM, Nuechterlein KH. Event-related potential correlates of linguistic information processing in schizophrenics. Biological Psychiatry. 42: 596-608. PMID 9376456 DOI: 10.1016/S0006-3223(96)00410-6  0.315
1997 Green MF, Nuechterlein KH, Breitmeyer B. Backward masking performance in unaffected siblings of schizophrenic patients. Evidence for a vulnerability indicator. Archives of General Psychiatry. 54: 465-72. PMID 9152100 DOI: 10.1001/Archpsyc.1997.01830170091012  0.509
1997 Hazlett EA, Dawson ME, Filion DL, Schell AM, Nuechterlein KH. Autonomic orienting and the allocation of processing resources in schizophrenia patients and putatively at-risk individuals. Journal of Abnormal Psychology. 106: 171-81. PMID 9131837 DOI: 10.1037//0021-843X.106.2.171  0.365
1997 Hazlett H, Dawson ME, Schell AM, Nuechterlein KH. Electrodermal activity as a prodromal sign in schizophrenia. Biological Psychiatry. 41: 111-3. PMID 8988801 DOI: 10.1016/S0006-3223(96)00351-4  0.481
1997 Moring J, Wynne LC, Asamow R, Nuechterlein K, Holzman PS, Hakko H, Tienari P. Attentional measures and eye tracking in the finnish adoptive study of schizophrenia Schizophrenia Research. 24: 243-244. DOI: 10.1016/S0920-9964(97)82700-4  0.479
1996 Bartzokis G, Nuechterlein KH, Marder SR, Mintz J, Dery K, Laack K. Age at illness onset and left temporal lobe length in males with schizophrenia. Psychiatry Research. 67: 189-201. PMID 8912958 DOI: 10.1016/0925-4927(96)02894-6  0.319
1995 Siegel BV, Nuechterlein KH, Abel L, Wu JC, Buchsbaum MS. Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls. Schizophrenia Research. 17: 85-94. PMID 8541254 DOI: 10.1016/0920-9964(95)00033-I  0.319
1995 Nuechterlein KH, Gitlin MJ, Subotnik KL. The early course of schizophrenia and long-term maintenance neuroleptic therapy. Archives of General Psychiatry. 52: 203-5. PMID 7872846 DOI: 10.1001/archpsyc.1995.03950150035006  0.355
1995 Moring J, Holzman P, Nuechterlein K, Asarnow R, Wynne L, Tienari P. Eye tracking and attentional measures in the finnish adoptive study of schizophrenia Schizophrenia Research. 15: 188. DOI: 10.1016/0920-9964(95)95578-W  0.479
1994 Strandburg RJ, Marsh JT, Brown WS, Asarnow RF, Guthrie D, Higa J, Yee-Bradbury CM, Nuechterlein KH. Reduced attention-related negative potentials in schizophrenic adults. Psychophysiology. 31: 272-81. PMID 8008791 DOI: 10.1111/J.1469-8986.1994.Tb02216.X  0.779
1994 Green MF, Nuechterlein KH, Mintz J. Backward masking in schizophrenia and mania. II. Specifying the visual channels. Archives of General Psychiatry. 51: 945-51. PMID 7979882 DOI: 10.1001/Archpsyc.1994.03950120017004  0.537
1994 Green MF, Nuechterlein KH, Mintz J. Backward masking in schizophrenia and mania. I. Specifying a mechanism. Archives of General Psychiatry. 51: 939-44. PMID 7979881 DOI: 10.1001/Archpsyc.1994.03950120011003  0.558
1994 Benedict RH, Harris AE, Markow T, McCormick JA, Nuechterlein KH, Asarnow RF. Effects of attention training on information processing in schizophrenia. Schizophrenia Bulletin. 20: 537-46. PMID 7973469 DOI: 10.1093/Schbul/20.3.537  0.467
1994 Dawson ME, Nuechterlein KH, Schell AM, Gitlin M, Ventura J. Autonomic abnormalities in schizophrenia. State or trait indicators? Archives of General Psychiatry. 51: 813-24. PMID 7944871 DOI: 10.1001/archpsyc.1994.03950100061006  0.419
1994 Nuechterlein KH, Dawson ME, Green MF. Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia. Acta Psychiatrica Scandinavica. Supplementum. 384: 71-9. PMID 7879647 DOI: 10.1111/J.1600-0447.1994.Tb05894.X  0.543
1994 Goldstein MJ, Rosenfarb I, Woo S, Nuechterlein K. Intrafamilial relationships and the course of schizophrenia. Acta Psychiatrica Scandinavica. Supplementum. 384: 60-6. PMID 7879645 DOI: 10.1111/J.1600-0447.1994.Tb05892.X  0.407
1993 Dawson ME, Hazlett EA, Filion DL, Nuechterlein KH, Schell AM. Attention and schizophrenia: impaired modulation of the startle reflex. Journal of Abnormal Psychology. 102: 633-41. PMID 8282934 DOI: 10.1037/0021-843X.102.4.633  0.453
1992 Dawson ME, Nuechterlein KH, Schell AM. Electrodermal anomalies in recent-onset schizophrenia: relationships to symptoms and prognosis. Schizophrenia Bulletin. 18: 295-311. PMID 1621075  0.352
1992 Nuechterlein KH, Dawson ME, Gitlin M, Ventura J, Goldstein MJ, Snyder KS, Yee CM, Mintz J. Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress. Schizophrenia Bulletin. 18: 387-425. PMID 1411329 DOI: 10.1093/Schbul/18.3.387  0.329
1992 Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, Katz M, Lohr J, Wu J, Lottenberg S, Jerabek PA. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Archives of General Psychiatry. 49: 935-42. PMID 1360198 DOI: 10.1001/Archpsyc.1992.01820120023005  0.443
1992 Green MF, Nuechterlein KH, Gaier DJ. Sustained and selective attention in schizophrenia. Progress in Experimental Personality & Psychopathology Research. 15: 290-313. PMID 1343109  0.588
1991 Hoffman RE, Buchsbaum MS, Escobar MD, Makuch RW, Nuechterlein KH, Guich SM. EEG coherence of prefrontal areas in normal and schizophrenic males during perceptual activation. The Journal of Neuropsychiatry and Clinical Neurosciences. 3: 169-75. PMID 1821231  0.355
1991 Nuechterlein KH, Green MF. Neuropsychological vulnerability or episode factors in schizophrenia? Behavioral and Brain Sciences. 14: 37-38. DOI: 10.1017/S0140525X00065250  0.612
1991 Green M, Nuechterlein K. Backward masking deficits in schizophrenia: Implicating a mechanism Schizophrenia Research. 4: 384. DOI: 10.1016/0920-9964(91)90321-H  0.676
1991 Ventura J, Nuechterlein K, Green M, Mintz J. Characterization of positive and negative symptoms in the early course of schizophrenia Schizophrenia Research. 4: 270-271. DOI: 10.1016/0920-9964(91)90133-C  0.618
1990 Green MF, Nuechterlein KH, Ventura J, Mintz J. The temporal relationship between depressive and psychotic symptoms in recent-onset schizophrenia. The American Journal of Psychiatry. 147: 179-82. PMID 2301655 DOI: 10.1176/Ajp.147.2.179  0.451
1989 Nuechterlein KH, Goldstein MJ, Ventura J, Dawson ME, Doane JA. Patient-environment relationships in schizophrenia. Information processing, communication deviance, autonomic arousal, and stressful life events. The British Journal of Psychiatry. Supplement. 84-9. PMID 2605027 DOI: 10.1192/S0007125000296049  0.35
1989 Green MF, Nuechterlein KH, Satz P. The relationship of symptomatology and medication to electrodermal activity in schizophrenia. Psychophysiology. 26: 148-57. PMID 2567035 DOI: 10.1111/J.1469-8986.1989.Tb03147.X  0.475
1989 Guich SM, Buchsbaum MS, Burgwald L, Wu J, Haier R, Asarnow R, Nuechterlein K, Potkin S. Effect of attention on frontal distribution of delta activity and cerebral metabolic rate in schizophrenia. Schizophrenia Research. 2: 439-48. PMID 2487185 DOI: 10.1016/0920-9964(89)90012-1  0.513
1989 Swanson JM, Nuechterlein K, Asarnow R, Taylor E, Hunt R, Shaywitz R, Shaywitz S, Potkin S, Early T, Cloninger CR, Posner M. Use of a common software system for collaborative clinical research on attentional processes in schizophrenia and ADHD Behavior Research Methods, Instruments, & Computers. 21: 250-254. DOI: 10.3758/Bf03205590  0.418
1989 Nuechterlein KH, Goldstein MJ, Ventura J, Dawson ME, Doane JA. Patient-environment relationship in schizophrenia. Information processing, communication deviance, autonomic arousal, and stressful life events British Journal of Psychiatry. 155: 84-89.  0.35
1988 Green MF, Nuechterlein KH. Neuroleptic effects on electrodermal responsivity to soft tones and loud noise in schizophrenia. Psychiatry Research. 24: 79-86. PMID 2899332 DOI: 10.1016/0165-1781(88)90143-6  0.525
1986 Nuechterlein KH, Snyder KS, Dawson ME, Rappe S, Gitlin M, Fogelson D. Expressed emotion, fixed-dose fluphenazine decanoate maintenance, and relapse in recent-onset schizophrenia. Psychopharmacology Bulletin. 22: 633-9. PMID 3797570  0.374
1986 Nuechterlein KH, Edell WS, Norris M, Dawson ME. Attentional vulnerability indicators, thought disorder, and negative symptoms. Schizophrenia Bulletin. 12: 408-26. PMID 3764359  0.701
1986 Nuechterlein KH. Childhood precursors of adult schizophrenia. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 27: 133-44. PMID 3514643  0.42
1985 Nuechterlein KH, Dawson ME. Increased critical stimulus duration: vulnerability or episode indicator? Schizophrenia Bulletin. 11: 344-6. PMID 4035300  0.352
1984 Lukoff D, Snyder K, Ventura J, Nuechterlein KH. Life events, familial stress, and coping in the developmental course of schizophrenia. Schizophrenia Bulletin. 10: 258-92. PMID 6729412 DOI: 10.1093/Schbul/10.2.258  0.302
1984 Dawson ME, Nuechterlein KH. Psychophysiological dysfunctions in the developmental course of schizophrenic disorders. Schizophrenia Bulletin. 10: 204-32. PMID 6729410  0.393
1984 Nuechterlein KH, Dawson ME. Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophrenia Bulletin. 10: 160-203. PMID 6729409  0.365
1983 Asarnow RF, Nuechterlein KH, Marder SR. Span of apprehension performance, neuropsychological functioning, and indices of psychosis-proneness. The Journal of Nervous and Mental Disease. 171: 662-9. PMID 6631431 DOI: 10.1097/00005053-198311000-00004  0.352
1981 Nuechterlein KH, Soli SD, Garmezy N, Devine VT, Schaefer SM. A classification system for research in childhood psychopathology: part II. Validation research examining converging descriptions from the parent and from the child. Progress in Experimental Personality Research. 10: 163-202. PMID 7323294  0.585
1981 Soli SD, Nuechterlein KH, Garmezy N, Devine VT, Schaefer SM. A classification system for research in childhood psychopathology: part I. An empirical approach using factor and cluster analyses and conjunctive decision rules. Progress in Experimental Personality Research. 10: 115-61. PMID 7323293  0.58
1977 Nuechterlein KH. Refocusing on attentional dysfunctions in schizophrenia. Schizophrenia Bulletin. 3: 457-69. PMID 918576  0.5
1977 Nuechterlein KH. Reaction time and attention in schizophrenia: a critical evaluation of the data and theories. Schizophrenia Bulletin. 3: 373-428. PMID 335494  0.374
1977 Spring B, Nuechterlein KH, Sugarman J, Matthysse S. The "new look" in studies of schizophrenic attention and information processing. Schizophrenia Bulletin. 3: 470-82. PMID 21447 DOI: 10.1093/Schbul/3.3.470  0.372
Show low-probability matches.